JP2002517185A5 - - Google Patents

Download PDF

Info

Publication number
JP2002517185A5
JP2002517185A5 JP2000552152A JP2000552152A JP2002517185A5 JP 2002517185 A5 JP2002517185 A5 JP 2002517185A5 JP 2000552152 A JP2000552152 A JP 2000552152A JP 2000552152 A JP2000552152 A JP 2000552152A JP 2002517185 A5 JP2002517185 A5 JP 2002517185A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000552152A
Other languages
Japanese (ja)
Other versions
JP2002517185A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/012253 external-priority patent/WO1999062942A2/en
Publication of JP2002517185A publication Critical patent/JP2002517185A/ja
Publication of JP2002517185A5 publication Critical patent/JP2002517185A5/ja
Withdrawn legal-status Critical Current

Links

JP2000552152A 1998-06-01 1999-06-01 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原 Withdrawn JP2002517185A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US8759898P 1998-06-01 1998-06-01
US60/087,598 1998-06-01
US9147498P 1998-06-29 1998-06-29
US60/091,474 1998-06-29
US12952199P 1999-04-14 1999-04-14
US60/129,521 1999-04-14
PCT/US1999/012253 WO1999062942A2 (en) 1998-06-01 1999-06-01 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008330218A Division JP2009148265A (ja) 1998-06-01 2008-12-25 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原

Publications (2)

Publication Number Publication Date
JP2002517185A JP2002517185A (ja) 2002-06-18
JP2002517185A5 true JP2002517185A5 (enExample) 2005-12-22

Family

ID=27375711

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000552152A Withdrawn JP2002517185A (ja) 1998-06-01 1999-06-01 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原
JP2008330218A Pending JP2009148265A (ja) 1998-06-01 2008-12-25 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008330218A Pending JP2009148265A (ja) 1998-06-01 2008-12-25 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原

Country Status (12)

Country Link
US (1) US20060275304A1 (enExample)
EP (1) EP1082341B1 (enExample)
JP (2) JP2002517185A (enExample)
AT (1) ATE490977T1 (enExample)
AU (2) AU773187B2 (enExample)
CA (1) CA2329137C (enExample)
CY (1) CY1111906T1 (enExample)
DE (1) DE69943020D1 (enExample)
DK (1) DK1082341T3 (enExample)
IL (1) IL139988A0 (enExample)
PT (1) PT1082341E (enExample)
WO (1) WO1999062942A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037667B1 (en) * 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
CA2344552A1 (en) * 1998-10-02 2000-04-13 Urogenesys, Inc. Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
WO2000023111A1 (en) * 1998-10-19 2000-04-27 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU4484400A (en) * 1999-04-23 2000-11-10 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
ES2317846T3 (es) 1999-08-12 2009-05-01 Agensys, Inc. Antigeno transmembranal de lectina tipo c en el cancer de prostata humano y usos del mismo.
AU2001269766A1 (en) * 2000-06-09 2001-12-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
ATE394491T1 (de) 2000-06-13 2008-05-15 Bayer Healthcare Ag Regulierung einer humanen transmembran- serinprotease
ATE429643T1 (de) * 2000-07-12 2009-05-15 Agensys Inc Neues tumor antigen das für diagnose und therapie von blasen-, eierstock-, lungen- und nierenkrebs verwendet werden kann
US6743592B1 (en) * 2000-07-25 2004-06-01 The Trustees Of The University Of Pennsylvania Methods, systems and kits for immuno-detection of epitopes expressed on molecules
US20040018973A1 (en) 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
WO2004092397A2 (en) * 2003-04-15 2004-10-28 Novartis Ag Tmprss2 regulatory sequences and uses thereof
WO2004097358A2 (en) * 2003-05-02 2004-11-11 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2)
CA2622295C (en) 2005-09-12 2019-01-15 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US9957569B2 (en) 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
EP2140022A2 (en) * 2007-03-30 2010-01-06 Oryzon Genomics, S.A. Method of nucleic acid analysis
ATE533861T1 (de) 2007-07-06 2011-12-15 Univ Michigan Mipol1-etv1-gen-neuanordnungen
US8106037B2 (en) 2007-08-03 2012-01-31 The Brigham And Women's Hospital, Inc. Identification and treatment of estrogen responsive prostate tumors
WO2011034906A2 (en) 2009-09-17 2011-03-24 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions
WO2013120929A1 (en) * 2012-02-15 2013-08-22 F. Hoffmann-La Roche Ag Fc-receptor based affinity chromatography
HUE045466T2 (hu) 2014-11-06 2019-12-30 Hoffmann La Roche Fc-régió-variánsok módosított FcRn-kötéssel és alkalmazási eljárások

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3040121B2 (ja) * 1988-01-12 2000-05-08 ジェネンテク,インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5288612A (en) * 1991-07-03 1994-02-22 The Scripps Research Institute Assay methods for detecting serum proteases, particularly activated protein C
EP0679189B1 (en) * 1993-01-15 2003-06-04 Genetics Institute, LLC Cloning of enterokinase and method of use
AR012035A1 (es) * 1997-02-25 2000-09-27 Corixa Corp Metodo para detectar el cancer de prostata, metodo para monitorear el desarrollo del cancer de prostata, anticuerpo monoclonal que se une a un polipeptido, una cantidad terapeutica eficaz de anticuerpos monoclonales para preparar medicamentos y equipo para diagnostico
CA2281952C (en) * 1997-02-25 2011-07-19 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6657056B2 (en) * 1997-02-25 2003-12-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6043033A (en) * 1997-02-27 2000-03-28 Incyte Pharmaceuticals, Inc. Human prostate-associated protease
US20030103981A1 (en) * 1997-02-27 2003-06-05 Incyte Genomics, Inc. Methods of use of a prostate-associated protease in the diagnosis and treatment of prostate cancer
US20020119531A1 (en) * 1997-02-27 2002-08-29 Olga Bandman Prostate-associated protease antibody
US6500938B1 (en) * 1998-01-30 2002-12-31 Incyte Genomics, Inc. Composition for the detection of signaling pathway gene expression
AU4839999A (en) * 1998-06-29 2000-01-17 Myriad Genetics, Inc. Tmprss2 is a tumor suppressor
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
US6331427B1 (en) * 1999-03-26 2001-12-18 Millennium Pharmaceuticals, Inc. Protease homologs
US20020192763A1 (en) * 2000-04-17 2002-12-19 Jiangchun Xu Compositions and methods for the therapy and diagnosis of prostate cancer
US20020160382A1 (en) * 2000-10-11 2002-10-31 Lasek Amy W. Genes expressed in colon cancer
US20030065157A1 (en) * 2001-04-04 2003-04-03 Lasek Amy W. Genes expressed in lung cancer

Similar Documents

Publication Publication Date Title
BE2015C018I2 (enExample)
BE2013C015I2 (enExample)
BE2013C001I2 (enExample)
BE2012C036I2 (enExample)
BE1025464I2 (enExample)
BE2008C046I2 (enExample)
BE2010C011I2 (enExample)
JP2002519753A5 (enExample)
JP2002502653A5 (enExample)
JP2002514834A5 (enExample)
JP2002508601A5 (enExample)
BE2008C047I2 (enExample)
JP2002531188A5 (enExample)
BE2011C004I2 (enExample)
JP2002501359A5 (enExample)
JP2002517185A5 (enExample)
JP2002518607A5 (enExample)
JP2002507043A5 (enExample)
JP2002523210A5 (enExample)
JP2002511359A5 (enExample)
JP2001133273A5 (enExample)
JP2002519959A5 (enExample)
JP2002527960A5 (enExample)
CN3122950S (enExample)
CN3098146S (enExample)